AU2199500A - Gastric retention dosage form having multiple layers - Google Patents

Gastric retention dosage form having multiple layers

Info

Publication number
AU2199500A
AU2199500A AU21995/00A AU2199500A AU2199500A AU 2199500 A AU2199500 A AU 2199500A AU 21995/00 A AU21995/00 A AU 21995/00A AU 2199500 A AU2199500 A AU 2199500A AU 2199500 A AU2199500 A AU 2199500A
Authority
AU
Australia
Prior art keywords
dosage form
multiple layers
gastric retention
retention dosage
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21995/00A
Inventor
David E Edgren
Francisco Jao
Patrick S.L. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AU2199500A publication Critical patent/AU2199500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU21995/00A 1998-12-23 1999-12-16 Gastric retention dosage form having multiple layers Abandoned AU2199500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11356098P 1998-12-23 1998-12-23
US60113560 1998-12-23
PCT/US1999/030343 WO2000038650A1 (en) 1998-12-23 1999-12-16 Gastric retention dosage form having multiple layers

Publications (1)

Publication Number Publication Date
AU2199500A true AU2199500A (en) 2000-07-31

Family

ID=22350139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21995/00A Abandoned AU2199500A (en) 1998-12-23 1999-12-16 Gastric retention dosage form having multiple layers

Country Status (2)

Country Link
AU (1) AU2199500A (en)
WO (1) WO2000038650A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002355686B2 (en) * 2001-07-04 2007-11-29 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20060013876A1 (en) * 2002-06-26 2006-01-19 Lohray Braj B Novel floating dosage form
WO2004078111A2 (en) * 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
WO2006077494A2 (en) * 2005-01-24 2006-07-27 Ranbaxy Laboratories Limited A process for preparing solid dosage forms for extended-release of biguanide and sulfonylurea
WO2006092711A2 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Extended release tablets of metformin and glipizide
WO2014100077A1 (en) * 2012-12-21 2014-06-26 Merck Sharp & Dohme Corp. Gastro-retentive formulations
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188212B (en) * 1985-12-20 1988-01-07 Paolo Colombo SYSTEM FOR THE RELEASE SPEED OF ACTIVE SUBSTANCES
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention

Also Published As

Publication number Publication date
WO2000038650A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU2791599A (en) Extended release dosage form
AU6356799A (en) Tablet package
AU6483299A (en) Ampic dram
AU3977099A (en) Controlled release oral dosage form
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
ZA99454B (en) Novel dosage form.
AU2740299A (en) Electroluminescent devices
AU2529099A (en) Electroluminescent devices
AU7924598A (en) Fast flattening packaging
AU8547198A (en) Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase
AU4222099A (en) Improved package design
AU8495998A (en) Improved dosage units
AU2199500A (en) Gastric retention dosage form having multiple layers
AU1424200A (en) Compounds
AU1409100A (en) Drugs
AUPP393798A0 (en) Joiner
AU1434500A (en) Compounds
AU1151300A (en) Medicament transferring device
AU1195600A (en) New package
AU6480299A (en) Pharmaceutical compounds
AU9321198A (en) Dosage forms having improved release properties
AU1688099A (en) Pharmaceutical preparation
AU1800700A (en) Ikk3 kinase
AU4919399A (en) Package combination
AUPP247498A0 (en) Improved palletizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase